This study is in progress, not accepting new patients
Convalescent Plasma to Limit SARS-CoV-2 Associated Complications
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UC Irvine UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Johns Hopkins University
- ID
- NCT04373460
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 1344 study participants
- Last Updated